Burden of hospitalization for gastrointestinal tract cancer patients - Results from a cross-sectional study in Tehran

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 1, 2009, Pages 107-110

  Pourhoseingholi, Mohamad Amin ^a   Vahedi, Mohsen ^a   Moghimi Dehkordi, Bijan ^a   Pourhoseingholi, Asma ^a   Ghafarnejad, Fatemeh ^a   Maserat, Elham ^a   Safaee, Azadeh ^a   Mansoori, Babak Khoshkrood ^a   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

GI tract cancers; Hospitalization; Iran

Indexed keywords

EID: 67650898925     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ahmedin J, Andrea T, Taylor M, Micheal T, (2002). Cancer statistics 2002. CA Cancer J Clin, 52, 32-47.
2. Cancer incidence in the Tehran Metropolita, (2007). Second report of the Tehran Population-Based cancer registry, the cancer Institute cancer research centre.
3. Crawford JM, (1991). The gastrointestinal tract: malignant tumors. In:Robbins SL, Cotran RS, Kumar V eds. Robbins pathologic basis of disease. WB Saunders Co Philadelphia P.897-902.
4. Enzinger PC, Mayer RJ, (2003). Esophageal cancer. N Engl J Med, 349, 2241-52.
5. Fritz PA, Percy C, Jack A, et al, (2000). International classification of diseases for oncology. 3rd edition. Geneva: World Health Organization.
6. Haghighi P, Nasr K, Mohallatee EA, et al, (1977). Colorectal polyps and carcinoma in Southern Iran. Cancer, 39, 274-8.
7. James AS, Campbell MK, Hudson MA, (2002). Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior? Cancer Epidemiol Biomarkers Prev, 11, 529-534.
8. Keighley MRB, (2004). Gastrointestinal cancers in Europe. The Burden of Gastrointestinal Diseases in Europe. Report of United European Gastroenterology Federation.
9. Moghimi-Dehkordi B, Safaee A, Zali MR, (2008). Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis, 23, 683-8.
10. Mohebbi M, Mahmoodi M, Wolfe R, et al, (2008). Geographical spread of gastrointestinal tract cancer incidence in the Caspian Sea region of Iran: spatial analysis of cancer registry data. BMC Cancer, 8, 137.
11. Mosavi-Jarrahi A, Mohagheghi MA, (2006). Epidemiology of esophageal cancer in the high-risk population of Iran. Asian Pac J Cancer Prev, 7, 375-80.
12. Naghavi N, (2004). Death report from 23 provinces in Iran. 1st edition. Tehran: Ministry of Health.
13. Parkin DM, (2004). International variation. Oncogene, 23, 6329- 40.
14. Parkin DM, Bray FI, Devesa SS, (2001). Cancer burden in the year 2000. The global picture. Eur J Cancer, 37 Suppl 8, S4-S66.
15. Parkin DM, Pisani P, Ferlay J, (1993). Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer, 54, 594-606.
16. Pourhoseingholi MA, Hajizadeh E, Dehkordi BM, et al, (2007). Comparing Cox regression and parametric models for survival of patients with gastric carcinoma. Asian Pac J Cancer Prev, 8, 412-6.
17. Sadjadi A, Nouraie M, Malekzadeh R, (2005). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359-60.
18. Safaee A, Moghimi-Dehkordi B, Fatemi SR, et al, (2008). Colorectal cancer in iran: an epidemiological study. Asian Pac J Cancer Prev, 9, 123-6.
19. Stone WL, Krishnan K, Campbell SE, Qui M, Whaley SG, Yang H, (2004). Tocopherols and the treatment of colon cancer. Ann NY Acad Sci, 1031, 223-33.
20. Vakili C, Fatourechi V, (1976). Age distribution of patients with carcinoma of the colon in a general hospital in Iran. Surgery, 79, 118-9.
21. Walsh JM, Terdiman JP, (2003). Colorectal cancer screening: clinical applications. JAMA, 289, 1297-302.
22. World Health Organization, (2002). Cancer Incidence in Five Continents, Vol. 8. Lyon: IARC Press; IARC Scientific Publication No. 155.
23. Yavari P, Hislop TG, Bajdik C, et al, (2006). Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev, 7, 86-90.